期刊文献+

涕灭威的生理药代动力学/药效学模型在风险评估中的应用

The Application of the PBPK/PD Model for Aldicarb Risk Assessment
原文传递
导出
摘要 目的:对大鼠和人急性口服涕灭威所致乙酰胆碱酯酶(AChE)抑制的无明显不良反应剂量(NOAEL)进行估算,并探讨若饮用美国4个不同地区含有涕灭威残量的地下水而带来的健康影响。方法:采用已构建的大鼠和人的生理药代动力学/药效学(PBPK/PD)模型进行模拟运算。结果:大鼠血液和脑内AChE抑制的NOAEL模拟值分别为0.0169和0.0158 mg/kg(文献报道为0.03和0.06 mg/kg)。模型预测人血和脑AChE抑制的NOAEL值为0.0052和0.0055 mg/kg(文献值为0.01和0.025 mg/kg)。如饮用污染的地下水,所致AChE的抑制对人体不构成显著影响。结论:本模型有助于涕灭威的健康风险评估。 Objective: To estimate the No Observable Adverse Effect Level (NOAEL) in rats and humans and to evaluate the health effects if a normal adult drinks the aldicarb contaminated underground water from four US geographic areas. Methods: The PBPK/ PI) models previously constructed for rats and humans were used for the model simnlatians. Results: Simulations showed the NOAEL value for the AChE inhibition in the blood and brain was 0.0169 and 0. 0158 mg/kg, respectively, for the rat versus the reported 0.03 and 0. 06 mg/kg. Human NOAEL was 0.0052 and 0. 0055 mg/kg, respectively, versus reported 0.01 and 0.025 mg/kg. Model simulation of drinking the underground water showed trace level of AChE inhibition. Conclusion: PBPK/PD modeling is helpful in the risk assessment for aldicarh exposure.
出处 《中国伤残医学》 2014年第7期30-31,共2页 Chinese Journal of Trauma and Disability Medicine
关键词 涕灭威 PBPK PD模型 风险评估 Aldicarb PBPK/PD model Risk assessment
  • 相关文献

参考文献1

二级参考文献13

  • 1Pelekis M, Edmond C. Physiological modeling and derivation of the rat to human toxicokinetic uncertainty factor for the car- bamate pesticide aldicarb [ J ]. Environ Toxicol Pharmacol, 2009,28 : 179-191. 被引量:1
  • 2Blancato JN, Power FW, Brown RN, et al. Exposure Related Dose Estimating Model (ERDEM) : A Physiologically Based Pharmacokinetic and Pharmacodynamic ( PBPK/PD ) model for assessing human exposure and risk. U. S. environmental protection agency, Washington, DC. 2006, EPA/600/R-06/ 061 (NTIS PB2006-114712). http://epa, gov/heasd/prod- ucts/erdem/237 edrb05 -Report. pdf. 被引量:1
  • 3Zhang X, Tsang AM, Okino MS, et al. A physiologically based pharmacokinetic/pharmacodynamic model for carbofuran in sprague-dawley rats using the exposure-related dose estimating model[J]. Toxicol Sci,2007,100(2) :345-359. 被引量:1
  • 4Knaak JB, Dary CC, Okino MS, et al. Parameters for carba- mate pesticide QSAR and PBPK/PD models for human risk assessment [J]. Environ Contam Toxico1,2008 ,193 :53-212. 被引量:1
  • 5Pelekis M, Krishnan K. Determination of the rate of aldicarb sulphoxidation in rat liver, kidney and lung microsomes [ J ]. Xenobiotica, 1997,27 ( 11 ) : 1113-1120. 被引量:1
  • 6Brown, RP, Delp, Lindstedt SL, et al. Physiological parameter values for physiologically based pharmacokinetic models [ J ]. Toxicol lnd Health, 1997,13:407-484. 被引量:1
  • 7Sweeney LM, Gargas ML, Strother DE, et al. Physiologically based pharmacokinetic model parameter estimation and sensi- tivity and variability analyses for acrylonitrile disposition in humans[ J]. Toxicol Sci ,2003,71 ( 1 ) :27-40. 被引量:1
  • 8Levitt DG, Schnider TW. Human physiologically based phar- macokinetic model for propofol [ J ]. BMC Anesthesiol, 2005,5 (1) :1-29. 被引量:1
  • 9Merrill EA, Clewell RA,Robinson PJ, et al. PBPK model for radioactive iodide and perchlorate kinetics and perchlorate-in- duced inhibition of iodide uptake in humans[ J]. Toxicol Sci, 2005,83( 1 ) :25-43. 被引量:1
  • 10Corley RA, Bartels MJ, Carney EW, et al. Development of a physiologically based pharmaeokinetic model for ethylene gly- col and its metabolite, glycolic acid, in rats and humans [ J ]. Toxicol Sci,2005,85 (.1) :476-490. 被引量:1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部